Medistim ASAFRA:MD1 -1.49%100 PB Ratio is 8.02 as of Jul. 06, 2026, which is 21% below its 10-year median of 10.17. GuruFocus rates FRA:MD1 with a GF Score™ of 100/100 and a GF Value™ of €23.04 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 788 Medical Devices & Instruments companies, Medistim ASA ranks worse than 88.2% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-06), Medistim ASA's share price is €19.90. Medistim ASA's Book Value per Share for the quarter that ended in Mar. 2026 was €2.48. Hence, Medistim ASA's PB Ratio of today is 8.02.
Good Sign:
Medistim ASA stock PB Ratio (=8.23) is close to 1-year low of 7.53.
The historical rank and industry rank for Medistim ASA's PB Ratio or its related term are showing as below:
FRA:MD1'
s PB Ratio Range Over the Past 10 Years
Min: 5.86 Med: 10.17 Max: 26.63
Current: 8.23
During the past 13 years, Medistim ASA's highest PB Ratio was 26.63. The lowest was 5.86. And the median was 10.17.
FRA:MD1's PB Ratio is ranked worse than 88.2% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs FRA:MD1: 8.23
During the past 12 months, Medistim ASA's average Book Value Per Share Growth Rate was 8.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 12.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medistim ASA was 33.20% per year. The lowest was 2.90% per year. And the median was 11.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medistim ASA PB Ratio Related Terms
Medistim ASA PB Ratio Historical Data
* Premium members only.
The historical data trend for Medistim ASA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medistim ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medistim ASA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Medistim ASA's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medistim ASA (FRA:MD1) has a PB Ratio of 8.02 as of Jul. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medistim ASA and its competitors. This is 21% below median its historical median of 10.17. Over the past decade, Medistim ASA's PB Ratio has ranged from 5.86 to 26.63. According to the industry distribution chart, Medistim ASA ranks #695 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 88.2%.
Is Medistim ASA's PB Ratio too high?
Medistim ASA's current PB Ratio of 8.02 is 21% below median its 10-year median of 10.17. Over the past 10 years, this metric has ranged from a low of 5.86 to a high of 26.63. The Medical Devices & Instruments industry median PB Ratio is 2.07. Medistim ASA's value of 8.02 is 288.4% above this industry median. Based on the distribution chart, Medistim ASA ranks #695 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medistim ASA has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #695 out of 788 companies for PB Ratio. This places Medistim ASA in the lower half of its industry. The industry median PB Ratio is 2.07. Medistim ASA's value of 8.02 is 288.4% above this benchmark. Historically, Medistim ASA's own PB Ratio has ranged from 5.86 to 26.63 over the past decade. While the company's 10-year median is 10.17 vs. the industry median of 2.07, Medistim ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current PB Ratio of 8.02 is 288.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current PB Ratio is 8.02, which is 21% below median its own 10-year median of 10.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (FRA:MD1) is currently considered Modestly Undervalued. The stock's GF Value™ is €23.04, compared to a current price of €19.90 — trading 13.6% below its estimated fair value. The current PB Ratio is 8.02, which is 21% below median its 10-year median of 10.17 and 288.4% above the Medical Devices & Instruments industry median of 2.07. Medistim ASA's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medistim ASA (FRA:MD1), the current PB Ratio is 8.02 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (FRA:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €19.90 is trading 13.6% below its estimated GF Value™ of €23.04.
GuruFocus considers Medistim ASA to be Modestly Undervalued.
Key valuation signals for FRA:MD1:
PB Ratio: 8.02 (21% below median its 10-year median of 10.17)
GF Value™: €23.04 vs. price of €19.90 (13.6% below fair value)
Industry Position: 288.4% above the Medical Devices & Instruments median (#695 of 788)
No single metric tells the full story. See the FRA:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
100GF Score
Get the complete analysis for FRA:MD1
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MD1 has been successfully added to your 
